Autism Spectrum Disorder Trial, Recruiting NCT06698588 Sponsor: Swansea University Condition: Autism Spectrum Disorder
Back to Autism Spectrum Disorder

Autism Spectrum Disorder Trial, Recruiting

NCT06698588
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Your child scores above 5 on a specific autism-related questionnaire (called the Autism Spectrum Quotient 10)
  • OR your child scores above 64 on specific sections (inattention or hyperactivity) of a standard ADHD parent rating form (called the Conners 3 Short Parent Form)
  • OR your child scores above 30 on a children's sleep habits questionnaire
  • Your child is able to swallow capsules

Who may not be able to join:

  • Children with a serious mental health condition that is likely to need hospital treatment, such as psychotic disorders or eating disorders (note: having a diagnosis of mood, anxiety, sleep, or other neurodevelopmental conditions does not automatically exclude a child, as these are common alongside ADHD and autism)
  • Children with severe learning difficulties, such as Down syndrome
  • Children with any serious medical condition
  • Children who have a known allergy to any of the ingredients in the treatment being studied, or to closely related substances (confirm with trial site for full ingredient details)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 01792295607

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Swansea University
Registry
ClinicalTrials.gov
Start date
7 November 2024
Est. completion
1 June 2025

Where this trial is recruiting

🇬🇧 United Kingdom

Primary endpoints

Changes in the network structure of symptoms before and after intervention.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov